November 8, 2023
Michael Macilquham appointed Chief Executive Officer, brings bold vision and leadership to solve healthcare challenges with leading-edge technology.
Sydney, Australia: Nicolab, a renowned healthcare technology solutions provider, revealed a pivotal leadership change today as it appointed Michael Macilquham as its new Chief Executive Officer, signaling a strategic direction for the company’s expansion phase. Boasting 25 years of clinical and commercial experience in the healthcare sector, he has served as the Chief Commercial Officer since his appointment earlier this year.
After a period of dedicated service, Merel Boers has stepped down from her position as CEO and will remain working for the company as co-Founder and Director. Under Boers’ leadership, the company successfully launched the company’s flagship product, StrokeViewer, swiftly becoming a market leader in The Netherlands and expanding to over 200 hospitals worldwide, including prestigious groups such as the US Department of Veterans Affairs. Following a period of maternity leave, Boers will resume her dedicated focus on cultivating pivotal strategic partnerships and overseeing the introduction of several transformative products.
Boers remarked: “I believe this transition will strengthen our organisation and enable us to reach new heights. I’m proud of our successes to date, and am confident that we can reach many more. Michael is well-suited to the CEO role and to lead Nicolab to grasp the commercial growth opportunities that lie ahead. My dedication will naturally remain firmly with our company”.
Macilquham supported this, stating: “This leadership transition underscores our commitment to accelerated growth and commercial success. Merel has been with Nicolab from the start and her contributions are, and will continue to be, an immense asset to the company. From here, my focus is on harnessing customer and industry partnerships to foster a customer-centric approach, whilst simultaneously prioritising revenue and the enhancement of our technology portfolio.”
This appointment signifies an important transition for Nicolab, as the company pivots from its foundation in clinical research and early market entry, towards a more commercially driven global focus. Over the next 36 months, the company has outlined plans for the launch of multiple products that will significantly augment the capabilities of healthcare professionals and ultimately transform patient care across the continuum of healthcare.
“Michael’s strong strategic expertise, forward-thinking approach and commercial acumen bring a dynamic perspective to guide Nicolab towards greater operational efficiency and commercial success. His leadership will play a pivotal role in our mission to empower healthcare professionals with quick and reliable access to vital information when it matters most,” commented Paul Lappin, Chairman of Nicolab.
Throughout his career, Macilquham has established a reputation as an innovative leader at the forefront of cutting-edge technologies in the medical imaging industry, consistently challenging established norms. During his tenure as Nicolab’s CCO, he has demonstrated his capacity to lead the company effectively, balancing fiscal responsibility whilst maintaining a well-rounded outlook. By placing a strong emphasis on key partnerships, he has instilled the organisation with a vision to propel Nicolab toward the realisation of its mission.
Paul Lappin – Chairman, Nicolab
For further information please contact: